Table 3.
Evaluated Parameters | Isotropic Sequences | 2D Sequences Perpendicular to the Tumor—MS 2 mm | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
T2-Weighted | T1-Weighted Before Contrast | T1-Weighted After Contrast | ||||||||||
MS TSE | 3D TSE SPIR | MS TSE | MS TSE SPIR | 3D TSE | 3D TFE | MS TSE SPIR | 3D TSE SPIR | 3D TFE PROSET | MS T2 | MS T1 | MS T1 SPIR Gd | |
In-plane image quality | ||||||||||||
General image quality | ++ | + | + | + | +− | +− | + | +− | + | + | + | ++ |
Contrast | + | ++ | +− | + | +− | + | ++ | + | ++ | ++ | + | ++ |
Outer limit of sclera | ++ | + | + | + | + | − | + | + | − | ++ | ++ | + |
Outer limits of tumor | +− | +− | + | + | +− | − | ++ | + | − | + | + | + |
Differentiate tumor vs RD | ++ | ++ | + | ++ | ||||||||
3D analysis | ||||||||||||
Geometrical accuracy | ||||||||||||
Good of complete eye | 75% | 78% | 44% | 44% | 77% | 100% | 50% | 88% | 100% | |||
Small local artefacts | 25% | 22% | 33% | 55% | 11% | 0% | 25% | 13% | 0% | |||
Not usable | 0% | 0% | 22% | 0% | 11% | 0% | 25% | 0% | 0% | |||
Outer limit of sclera | ++ | + | +− | +− | + | − | +− | + | − |